Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
<p>Abstract</p> <p>The lowering of high blood pressure is supposed to protect target organs from hypertensive damage. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial was designed to compare the cardioprotective properties of three antihypertensives f...
Main Authors: | Gavras Haralambos, Gavras Irene |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2001-11-01
|
Series: | Current Controlled Trials in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.1186/cvm-2-6-257 |
Similar Items
-
Comments on ALLHAT and doxazosin
by: Krakoff Lawrence R
Published: (2001-11-01) -
Cardiac and Vascular α<sub>1</sub>-Adrenoceptors in Congestive Heart Failure: A Systematic Review
by: Gizem Kaykı-Mutlu, et al.
Published: (2020-11-01) -
Persistence to Medications for Benign Prostatic Hyperplasia/Benign Prostatic Obstruction-Associated Lower Urinary Tract Symptoms in the ASL TO4 Regione Piemonte (Italy)
by: Lucrezia Greta Armando, et al.
Published: (2022-12-01) -
EEG Frequency Correlates with α<sub>2</sub>-Receptor Density in Parkinson’s Disease
by: Adam F. Kemp, et al.
Published: (2024-02-01) -
Characterization of Chicken α<sub>2A</sub>-Adrenoceptor: Molecular Cloning, Functional Analysis, and Its Involvement in Ovarian Follicular Development
by: Biying Jiang, et al.
Published: (2022-06-01)